Medical Writer

Costa Rica

Apply with AI Apply

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Clinical Research, PharmaceuticalsIndustries

Requirements

Candidates must possess a Bachelor's Degree in Life or Physical Sciences, such as Biology or Chemistry. A strong understanding of clinical documentation and regulatory success is essential. Detail-orientation and a passion for medical writing are required.

Responsibilities

The Medical Writer will review study protocols, electronic Case Report Forms (eCRFs), and related documents for accuracy and completeness. They will create, modify, and finalize various charters, Clinical Data Transfer Plans (CDTPs), and Reader Training Packages (RTPs). Responsibilities also include generating compliance reports, reviewing investigator meeting slides, and supervising Associate Medical Writers. The role involves updating Standard Operating Procedures (SOPs), maintaining the MedComm database, and providing guidance to project teams. Additionally, the Medical Writer will ensure quality service by adhering to SOPs, contributing to team efforts, and staying current with industry knowledge and training activities.

Skills

Clinical Documentation

Regulatory Writing

Protocol Review

eCRF/CRF Review

Charter Creation

Clinical Data Transfer Plans

Reader Training Package

Compliance Reports

Investigator Meeting Slides

Medical Writing

Communication

Attention to Detail

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free